EN
HI

THYROCARE TECH Share price

THYROCARE

HealthcareMid

920.45

7.10 (0.78%)
NSE
BSE
Last updated on 6 May, 2025 | 14:31 IST
BUYSELL
Today's High

911.30

Today's Low

945.00

52 Week Low

1055.00

52 Week High

1055.00

The current prices are delayed, login to your account for live prices

Thyrocare Technologies Chart

THYROCARE TECH Share Key Metrics

Volume
1.28 L
Market Cap
4840.16 CR
LTQ@LTP
1@920.45
ATP
928.04
Var Margin
2000
Circuit Range
730.7-1096
Delivery %
39.16
Value
11.89 CR
ASM/GSM
No
Market Lot
1

THYROCARE TECH Futures & Options

Data Not Found

THYROCARE TECH Corporate Actions

DateAgenda
2025-04-23Audited Results & Final Dividend
2025-01-23Quarterly Results
DateEvent TypeAgenda
2025-04-23Board MeetingAudited Results & Final Dividend
2025-01-23Board MeetingQuarterly Results

THYROCARE TECH News

Thyrocare Technologies shares soar nearly 17% as Q1 results impress D-Street

Jul 24 2024 14:41:59
Read More

About THYROCARE TECH

NSE : 17032  
BSE : 539871  
ISIN : INE594H01019  

The Company was incorporated as Thyrocare Technologies Limited on January 28 2000 at Mumbai as a public limited company under the Companies Act 1956. the Company was issued a certificate of commencement of business from the RoC on March 7 2000. Major events and milestones of the Company :2000-The Company was incorporated in the name and style of "Thyrocare Technologies Limited? and received a certificate for commencement of operations. 2001-The Company received ISO 9001 certification. -The Company commenced commercial operations under the brand name 'Thyrocare' pursuant to the acquisition of business of TDPL and TBPL (which were incorporated in 1996). 2005-The Company received NABL accreditation. 2006-The Company issued certain fully convertible debentures aggregating to 250 million to BCCL. 2007-The Company receives accreditation from the College of American Pathologists (CAP). 2010-The Company issued certain compulsorily convertible debentures aggregating to 250 million to Agalia. Agalia also acquired certain Equity Shares aggregating to 1250 million from the Promoters and certain other persons. -The Company launched wellness packages under the brand name "Aarogyam". 2011-The Company migrated to "total laboratory automation system" installed by Siemens for efficient handling of increasing volumes. 2012-NVP acquired certain Equity Shares aggregating to 1200 million from certain entities. 2013-EIF acquired certain Equity Shares from Agalia. -The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1000 scans in the first year of operation. 2014-The Company had installed India?s first and the world?s longest track automation system for seamless sample movements from Siemens Limited. -The Company commissioned the operations in medical cyclotron facility in Navi Mumbai. -The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1000 scans in the first year of operations. 2015-The Company opened RPLs in Delhi Coimbatore Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily. -The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name "WHATERS". These tests at present include physical and chemical testing elements testing microbiology testing pesticide testing and volatile organic compounds testing. -The Subsidiary has completed over 10000 scans at the PET-CT centres in New Delhi over 10000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1000 scans at the PET-CT centres in Hyderabad since inception.

THYROCARE TECH Management

NamePosition
Mr. Rahul Guha Managing Director & CEO
Mr. Dharmil Sheth Non Executive Director
Mr. Hardik Dedhia Non Executive Director
Mr. Dhaval Shah Non Executive Director
Mr. Gopalkrishna Shivram Hegde Independent Director
Read More

THYROCARE TECH FAQs

The Buying Price of THYROCARE TECH share is 464.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy THYROCARE TECH share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of THYROCARE TECH shares is 49.54. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio THYROCARE TECH shares is 8.83. Useful to assess the stock's value relative to its book value.

To assess THYROCARE TECH’s valuation compare Sector P/E, P/B which are 43.04 & 3.34 with sector averages, along with growth rates and financial metrics.

The Market Cap of THYROCARE TECH is 4840.16 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of THYROCARE TECH share price is 1055.00 & 571.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.